nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP1A2—Carmustine—lymphatic system cancer	0.166	0.234	CbGbCtD
Tranylcypromine—CYP2E1—Mitoxantrone—lymphatic system cancer	0.135	0.19	CbGbCtD
Tranylcypromine—CYP2C19—Teniposide—lymphatic system cancer	0.121	0.171	CbGbCtD
Tranylcypromine—CYP2C9—Teniposide—lymphatic system cancer	0.101	0.142	CbGbCtD
Tranylcypromine—CYP3A4—Cytarabine—lymphatic system cancer	0.0595	0.0837	CbGbCtD
Tranylcypromine—CYP3A4—Teniposide—lymphatic system cancer	0.0586	0.0824	CbGbCtD
Tranylcypromine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.041	0.0577	CbGbCtD
Tranylcypromine—CYP3A4—Vincristine—lymphatic system cancer	0.0282	0.0397	CbGbCtD
Tranylcypromine—Inappropriate antidiuretic hormone secretion—Vincristine—lymphatic system cancer	0.00391	0.0135	CcSEcCtD
Tranylcypromine—Myoclonus—Vincristine—lymphatic system cancer	0.00378	0.0131	CcSEcCtD
Tranylcypromine—Tenderness—Bleomycin—lymphatic system cancer	0.00312	0.0108	CcSEcCtD
Tranylcypromine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.003	0.0104	CcSEcCtD
Tranylcypromine—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.0029	0.01	CcSEcCtD
Tranylcypromine—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00288	0.00998	CcSEcCtD
Tranylcypromine—Numbness—Vincristine—lymphatic system cancer	0.00274	0.00949	CcSEcCtD
Tranylcypromine—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00269	0.0093	CcSEcCtD
Tranylcypromine—Sensory loss—Vincristine—lymphatic system cancer	0.00262	0.00908	CcSEcCtD
Tranylcypromine—Alopecia—Mechlorethamine—lymphatic system cancer	0.00255	0.00882	CcSEcCtD
Tranylcypromine—Neck stiffness—Methotrexate—lymphatic system cancer	0.00232	0.00801	CcSEcCtD
Tranylcypromine—Urinary incontinence—Carmustine—lymphatic system cancer	0.0023	0.00795	CcSEcCtD
Tranylcypromine—Sweating—Teniposide—lymphatic system cancer	0.00227	0.00785	CcSEcCtD
Tranylcypromine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00225	0.00777	CcSEcCtD
Tranylcypromine—Disorientation—Bleomycin—lymphatic system cancer	0.00221	0.00766	CcSEcCtD
Tranylcypromine—Haemoglobin—Teniposide—lymphatic system cancer	0.00214	0.00739	CcSEcCtD
Tranylcypromine—Nuchal rigidity—Methotrexate—lymphatic system cancer	0.00212	0.00736	CcSEcCtD
Tranylcypromine—Haemorrhage—Teniposide—lymphatic system cancer	0.00212	0.00735	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.002	0.00694	CcSEcCtD
Tranylcypromine—Flushing—Teniposide—lymphatic system cancer	0.00197	0.00683	CcSEcCtD
Tranylcypromine—Anorexia—Mechlorethamine—lymphatic system cancer	0.00195	0.00676	CcSEcCtD
Tranylcypromine—Chills—Teniposide—lymphatic system cancer	0.00191	0.0066	CcSEcCtD
Tranylcypromine—Alopecia—Teniposide—lymphatic system cancer	0.00188	0.0065	CcSEcCtD
Tranylcypromine—Haemoglobin—Fludarabine—lymphatic system cancer	0.00188	0.0065	CcSEcCtD
Tranylcypromine—Haemorrhage—Fludarabine—lymphatic system cancer	0.00187	0.00646	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00186	0.00643	CcSEcCtD
Tranylcypromine—Amnesia—Carmustine—lymphatic system cancer	0.00184	0.00636	CcSEcCtD
Tranylcypromine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00178	0.00616	CcSEcCtD
Tranylcypromine—Anaemia—Teniposide—lymphatic system cancer	0.00171	0.00592	CcSEcCtD
Tranylcypromine—Agitation—Teniposide—lymphatic system cancer	0.0017	0.00588	CcSEcCtD
Tranylcypromine—Chills—Fludarabine—lymphatic system cancer	0.00168	0.0058	CcSEcCtD
Tranylcypromine—Leukopenia—Teniposide—lymphatic system cancer	0.00166	0.00573	CcSEcCtD
Tranylcypromine—Alopecia—Fludarabine—lymphatic system cancer	0.00165	0.00571	CcSEcCtD
Tranylcypromine—Ataxia—Carmustine—lymphatic system cancer	0.00162	0.00562	CcSEcCtD
Tranylcypromine—Hypertension—Teniposide—lymphatic system cancer	0.0016	0.00553	CcSEcCtD
Tranylcypromine—Urinary retention—Vincristine—lymphatic system cancer	0.00157	0.00543	CcSEcCtD
Tranylcypromine—Ataxia—Vincristine—lymphatic system cancer	0.00155	0.00537	CcSEcCtD
Tranylcypromine—Confusional state—Teniposide—lymphatic system cancer	0.00152	0.00527	CcSEcCtD
Tranylcypromine—Oedema—Teniposide—lymphatic system cancer	0.00151	0.00522	CcSEcCtD
Tranylcypromine—Anaemia—Fludarabine—lymphatic system cancer	0.0015	0.0052	CcSEcCtD
Tranylcypromine—Agitation—Fludarabine—lymphatic system cancer	0.00149	0.00517	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00148	0.00512	CcSEcCtD
Tranylcypromine—Tachycardia—Teniposide—lymphatic system cancer	0.00147	0.0051	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00146	0.00505	CcSEcCtD
Tranylcypromine—Leukopenia—Fludarabine—lymphatic system cancer	0.00145	0.00504	CcSEcCtD
Tranylcypromine—Anorexia—Teniposide—lymphatic system cancer	0.00144	0.00498	CcSEcCtD
Tranylcypromine—Hypotension—Teniposide—lymphatic system cancer	0.00141	0.00488	CcSEcCtD
Tranylcypromine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0014	0.00485	CcSEcCtD
Tranylcypromine—Haemoglobin—Bleomycin—lymphatic system cancer	0.00138	0.00476	CcSEcCtD
Tranylcypromine—Haemorrhage—Bleomycin—lymphatic system cancer	0.00137	0.00474	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00136	0.00472	CcSEcCtD
Tranylcypromine—Confusional state—Fludarabine—lymphatic system cancer	0.00134	0.00463	CcSEcCtD
Tranylcypromine—Oedema—Fludarabine—lymphatic system cancer	0.00133	0.00459	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00131	0.00454	CcSEcCtD
Tranylcypromine—Decreased appetite—Teniposide—lymphatic system cancer	0.00131	0.00454	CcSEcCtD
Tranylcypromine—Vomiting—Mechlorethamine—lymphatic system cancer	0.0013	0.00451	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.0013	0.0045	CcSEcCtD
Tranylcypromine—Rash—Mechlorethamine—lymphatic system cancer	0.00129	0.00447	CcSEcCtD
Tranylcypromine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00129	0.00446	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00128	0.00444	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00128	0.00443	CcSEcCtD
Tranylcypromine—Flushing—Bleomycin—lymphatic system cancer	0.00127	0.0044	CcSEcCtD
Tranylcypromine—Anorexia—Fludarabine—lymphatic system cancer	0.00126	0.00438	CcSEcCtD
Tranylcypromine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00124	0.00431	CcSEcCtD
Tranylcypromine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00124	0.00428	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00123	0.00427	CcSEcCtD
Tranylcypromine—Musculoskeletal stiffness—Methotrexate—lymphatic system cancer	0.00123	0.00425	CcSEcCtD
Tranylcypromine—Chills—Bleomycin—lymphatic system cancer	0.00123	0.00425	CcSEcCtD
Tranylcypromine—Sweating—Vincristine—lymphatic system cancer	0.00122	0.00422	CcSEcCtD
Tranylcypromine—Nausea—Mechlorethamine—lymphatic system cancer	0.00122	0.00421	CcSEcCtD
Tranylcypromine—Alopecia—Bleomycin—lymphatic system cancer	0.00121	0.00419	CcSEcCtD
Tranylcypromine—Haemoglobin—Carmustine—lymphatic system cancer	0.0012	0.00416	CcSEcCtD
Tranylcypromine—Urticaria—Teniposide—lymphatic system cancer	0.0012	0.00415	CcSEcCtD
Tranylcypromine—Haemorrhage—Carmustine—lymphatic system cancer	0.0012	0.00414	CcSEcCtD
Tranylcypromine—Abdominal pain—Teniposide—lymphatic system cancer	0.00119	0.00413	CcSEcCtD
Tranylcypromine—Body temperature increased—Teniposide—lymphatic system cancer	0.00119	0.00413	CcSEcCtD
Tranylcypromine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00119	0.00412	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00119	0.00412	CcSEcCtD
Tranylcypromine—Sweating—Mitoxantrone—lymphatic system cancer	0.00119	0.00411	CcSEcCtD
Tranylcypromine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00115	0.004	CcSEcCtD
Tranylcypromine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00115	0.00399	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00114	0.00393	CcSEcCtD
Tranylcypromine—Constipation—Fludarabine—lymphatic system cancer	0.00113	0.00393	CcSEcCtD
Tranylcypromine—Pain—Fludarabine—lymphatic system cancer	0.00113	0.00393	CcSEcCtD
Tranylcypromine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00113	0.00392	CcSEcCtD
Tranylcypromine—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00112	0.00387	CcSEcCtD
Tranylcypromine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00111	0.00385	CcSEcCtD
Tranylcypromine—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00111	0.00385	CcSEcCtD
Tranylcypromine—Flushing—Carmustine—lymphatic system cancer	0.00111	0.00384	CcSEcCtD
Tranylcypromine—Anaemia—Bleomycin—lymphatic system cancer	0.0011	0.00381	CcSEcCtD
Tranylcypromine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00109	0.00378	CcSEcCtD
Tranylcypromine—Asthenia—Teniposide—lymphatic system cancer	0.00108	0.00375	CcSEcCtD
Tranylcypromine—Leukopenia—Bleomycin—lymphatic system cancer	0.00107	0.00369	CcSEcCtD
Tranylcypromine—Alopecia—Carmustine—lymphatic system cancer	0.00106	0.00366	CcSEcCtD
Tranylcypromine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00105	0.00363	CcSEcCtD
Tranylcypromine—Diarrhoea—Teniposide—lymphatic system cancer	0.00103	0.00357	CcSEcCtD
Tranylcypromine—Alopecia—Vincristine—lymphatic system cancer	0.00101	0.00349	CcSEcCtD
Tranylcypromine—Chills—Mitoxantrone—lymphatic system cancer	0.000997	0.00345	CcSEcCtD
Tranylcypromine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000982	0.0034	CcSEcCtD
Tranylcypromine—Confusional state—Bleomycin—lymphatic system cancer	0.000981	0.00339	CcSEcCtD
Tranylcypromine—Vision blurred—Carmustine—lymphatic system cancer	0.00098	0.00339	CcSEcCtD
Tranylcypromine—Tremor—Carmustine—lymphatic system cancer	0.000975	0.00337	CcSEcCtD
Tranylcypromine—Oedema—Bleomycin—lymphatic system cancer	0.000973	0.00337	CcSEcCtD
Tranylcypromine—Anaemia—Carmustine—lymphatic system cancer	0.000962	0.00333	CcSEcCtD
Tranylcypromine—Vomiting—Teniposide—lymphatic system cancer	0.00096	0.00332	CcSEcCtD
Tranylcypromine—Agitation—Carmustine—lymphatic system cancer	0.000956	0.00331	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000952	0.0033	CcSEcCtD
Tranylcypromine—Asthenia—Fludarabine—lymphatic system cancer	0.000952	0.00329	CcSEcCtD
Tranylcypromine—Rash—Teniposide—lymphatic system cancer	0.000952	0.00329	CcSEcCtD
Tranylcypromine—Dermatitis—Teniposide—lymphatic system cancer	0.000951	0.00329	CcSEcCtD
Tranylcypromine—Headache—Teniposide—lymphatic system cancer	0.000946	0.00327	CcSEcCtD
Tranylcypromine—Leukopenia—Carmustine—lymphatic system cancer	0.000931	0.00322	CcSEcCtD
Tranylcypromine—Anorexia—Bleomycin—lymphatic system cancer	0.000927	0.00321	CcSEcCtD
Tranylcypromine—Anaemia—Vincristine—lymphatic system cancer	0.000918	0.00318	CcSEcCtD
Tranylcypromine—Agitation—Vincristine—lymphatic system cancer	0.000913	0.00316	CcSEcCtD
Tranylcypromine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000911	0.00316	CcSEcCtD
Tranylcypromine—Hypotension—Bleomycin—lymphatic system cancer	0.000909	0.00315	CcSEcCtD
Tranylcypromine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000908	0.00314	CcSEcCtD
Tranylcypromine—Hypertension—Carmustine—lymphatic system cancer	0.000898	0.00311	CcSEcCtD
Tranylcypromine—Nausea—Teniposide—lymphatic system cancer	0.000897	0.0031	CcSEcCtD
Tranylcypromine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000894	0.00309	CcSEcCtD
Tranylcypromine—Leukopenia—Vincristine—lymphatic system cancer	0.000889	0.00308	CcSEcCtD
Tranylcypromine—Anxiety—Carmustine—lymphatic system cancer	0.000883	0.00306	CcSEcCtD
Tranylcypromine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000873	0.00302	CcSEcCtD
Tranylcypromine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000866	0.003	CcSEcCtD
Tranylcypromine—Hypertension—Vincristine—lymphatic system cancer	0.000857	0.00297	CcSEcCtD
Tranylcypromine—Confusional state—Carmustine—lymphatic system cancer	0.000856	0.00296	CcSEcCtD
Tranylcypromine—Oedema—Carmustine—lymphatic system cancer	0.000849	0.00294	CcSEcCtD
Tranylcypromine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000846	0.00293	CcSEcCtD
Tranylcypromine—Vomiting—Fludarabine—lymphatic system cancer	0.000843	0.00292	CcSEcCtD
Tranylcypromine—Rash—Fludarabine—lymphatic system cancer	0.000836	0.0029	CcSEcCtD
Tranylcypromine—Dermatitis—Fludarabine—lymphatic system cancer	0.000836	0.00289	CcSEcCtD
Tranylcypromine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000835	0.00289	CcSEcCtD
Tranylcypromine—Pain—Bleomycin—lymphatic system cancer	0.000832	0.00288	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000831	0.00288	CcSEcCtD
Tranylcypromine—Headache—Fludarabine—lymphatic system cancer	0.000831	0.00288	CcSEcCtD
Tranylcypromine—Tachycardia—Carmustine—lymphatic system cancer	0.000829	0.00287	CcSEcCtD
Tranylcypromine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000821	0.00284	CcSEcCtD
Tranylcypromine—Oedema—Vincristine—lymphatic system cancer	0.00081	0.00281	CcSEcCtD
Tranylcypromine—Anorexia—Carmustine—lymphatic system cancer	0.000809	0.0028	CcSEcCtD
Tranylcypromine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000802	0.00277	CcSEcCtD
Tranylcypromine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000796	0.00275	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000794	0.00275	CcSEcCtD
Tranylcypromine—Hypotension—Carmustine—lymphatic system cancer	0.000793	0.00275	CcSEcCtD
Tranylcypromine—Oedema—Mitoxantrone—lymphatic system cancer	0.000789	0.00273	CcSEcCtD
Tranylcypromine—Nausea—Fludarabine—lymphatic system cancer	0.000788	0.00273	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000784	0.00271	CcSEcCtD
Tranylcypromine—Shock—Mitoxantrone—lymphatic system cancer	0.000777	0.00269	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000773	0.00268	CcSEcCtD
Tranylcypromine—Urticaria—Bleomycin—lymphatic system cancer	0.000773	0.00267	CcSEcCtD
Tranylcypromine—Anorexia—Vincristine—lymphatic system cancer	0.000773	0.00267	CcSEcCtD
Tranylcypromine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00077	0.00267	CcSEcCtD
Tranylcypromine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000769	0.00266	CcSEcCtD
Tranylcypromine—Insomnia—Carmustine—lymphatic system cancer	0.000768	0.00266	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000763	0.00264	CcSEcCtD
Tranylcypromine—Paraesthesia—Carmustine—lymphatic system cancer	0.000762	0.00264	CcSEcCtD
Tranylcypromine—Hypotension—Vincristine—lymphatic system cancer	0.000757	0.00262	CcSEcCtD
Tranylcypromine—Somnolence—Carmustine—lymphatic system cancer	0.000755	0.00261	CcSEcCtD
Tranylcypromine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000752	0.0026	CcSEcCtD
Tranylcypromine—Ataxia—Methotrexate—lymphatic system cancer	0.000752	0.0026	CcSEcCtD
Tranylcypromine—Decreased appetite—Carmustine—lymphatic system cancer	0.000738	0.00255	CcSEcCtD
Tranylcypromine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000738	0.00255	CcSEcCtD
Tranylcypromine—Insomnia—Vincristine—lymphatic system cancer	0.000733	0.00254	CcSEcCtD
Tranylcypromine—Paraesthesia—Vincristine—lymphatic system cancer	0.000728	0.00252	CcSEcCtD
Tranylcypromine—Pain—Carmustine—lymphatic system cancer	0.000726	0.00251	CcSEcCtD
Tranylcypromine—Constipation—Carmustine—lymphatic system cancer	0.000726	0.00251	CcSEcCtD
Tranylcypromine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000709	0.00245	CcSEcCtD
Tranylcypromine—Decreased appetite—Vincristine—lymphatic system cancer	0.000705	0.00244	CcSEcCtD
Tranylcypromine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000702	0.00243	CcSEcCtD
Tranylcypromine—Feeling abnormal—Carmustine—lymphatic system cancer	0.0007	0.00242	CcSEcCtD
Tranylcypromine—Asthenia—Bleomycin—lymphatic system cancer	0.000698	0.00242	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000694	0.0024	CcSEcCtD
Tranylcypromine—Pain—Vincristine—lymphatic system cancer	0.000693	0.0024	CcSEcCtD
Tranylcypromine—Constipation—Vincristine—lymphatic system cancer	0.000693	0.0024	CcSEcCtD
Tranylcypromine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000686	0.00238	CcSEcCtD
Tranylcypromine—Pain—Mitoxantrone—lymphatic system cancer	0.000675	0.00234	CcSEcCtD
Tranylcypromine—Constipation—Mitoxantrone—lymphatic system cancer	0.000675	0.00234	CcSEcCtD
Tranylcypromine—Abdominal pain—Carmustine—lymphatic system cancer	0.000671	0.00232	CcSEcCtD
Tranylcypromine—Body temperature increased—Carmustine—lymphatic system cancer	0.000671	0.00232	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000663	0.00229	CcSEcCtD
Tranylcypromine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00065	0.00225	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000645	0.00223	CcSEcCtD
Tranylcypromine—Abdominal pain—Vincristine—lymphatic system cancer	0.000641	0.00222	CcSEcCtD
Tranylcypromine—Body temperature increased—Vincristine—lymphatic system cancer	0.000641	0.00222	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000637	0.0022	CcSEcCtD
Tranylcypromine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000627	0.00217	CcSEcCtD
Tranylcypromine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000624	0.00216	CcSEcCtD
Tranylcypromine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000624	0.00216	CcSEcCtD
Tranylcypromine—Vomiting—Bleomycin—lymphatic system cancer	0.000618	0.00214	CcSEcCtD
Tranylcypromine—Drowsiness—Methotrexate—lymphatic system cancer	0.000617	0.00213	CcSEcCtD
Tranylcypromine—Rash—Bleomycin—lymphatic system cancer	0.000613	0.00212	CcSEcCtD
Tranylcypromine—Dermatitis—Bleomycin—lymphatic system cancer	0.000613	0.00212	CcSEcCtD
Tranylcypromine—Asthenia—Carmustine—lymphatic system cancer	0.000609	0.00211	CcSEcCtD
Tranylcypromine—Sweating—Methotrexate—lymphatic system cancer	0.000591	0.00205	CcSEcCtD
Tranylcypromine—Asthenia—Vincristine—lymphatic system cancer	0.000582	0.00201	CcSEcCtD
Tranylcypromine—Diarrhoea—Carmustine—lymphatic system cancer	0.000581	0.00201	CcSEcCtD
Tranylcypromine—Nausea—Bleomycin—lymphatic system cancer	0.000578	0.002	CcSEcCtD
Tranylcypromine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000575	0.00199	CcSEcCtD
Tranylcypromine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000566	0.00196	CcSEcCtD
Tranylcypromine—Dizziness—Carmustine—lymphatic system cancer	0.000561	0.00194	CcSEcCtD
Tranylcypromine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000556	0.00193	CcSEcCtD
Tranylcypromine—Diarrhoea—Vincristine—lymphatic system cancer	0.000555	0.00192	CcSEcCtD
Tranylcypromine—Haemorrhage—Methotrexate—lymphatic system cancer	0.000554	0.00192	CcSEcCtD
Tranylcypromine—Hepatitis—Methotrexate—lymphatic system cancer	0.000554	0.00192	CcSEcCtD
Tranylcypromine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00054	0.00187	CcSEcCtD
Tranylcypromine—Vomiting—Carmustine—lymphatic system cancer	0.00054	0.00187	CcSEcCtD
Tranylcypromine—Dizziness—Vincristine—lymphatic system cancer	0.000536	0.00186	CcSEcCtD
Tranylcypromine—Rash—Carmustine—lymphatic system cancer	0.000535	0.00185	CcSEcCtD
Tranylcypromine—Dermatitis—Carmustine—lymphatic system cancer	0.000535	0.00185	CcSEcCtD
Tranylcypromine—Headache—Carmustine—lymphatic system cancer	0.000532	0.00184	CcSEcCtD
Tranylcypromine—Tinnitus—Methotrexate—lymphatic system cancer	0.000516	0.00179	CcSEcCtD
Tranylcypromine—Vomiting—Vincristine—lymphatic system cancer	0.000515	0.00178	CcSEcCtD
Tranylcypromine—Rash—Vincristine—lymphatic system cancer	0.000511	0.00177	CcSEcCtD
Tranylcypromine—Dermatitis—Vincristine—lymphatic system cancer	0.000511	0.00177	CcSEcCtD
Tranylcypromine—Headache—Vincristine—lymphatic system cancer	0.000508	0.00176	CcSEcCtD
Tranylcypromine—Nausea—Carmustine—lymphatic system cancer	0.000504	0.00175	CcSEcCtD
Tranylcypromine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000502	0.00174	CcSEcCtD
Tranylcypromine—Rash—Mitoxantrone—lymphatic system cancer	0.000498	0.00172	CcSEcCtD
Tranylcypromine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000497	0.00172	CcSEcCtD
Tranylcypromine—Chills—Methotrexate—lymphatic system cancer	0.000497	0.00172	CcSEcCtD
Tranylcypromine—Headache—Mitoxantrone—lymphatic system cancer	0.000494	0.00171	CcSEcCtD
Tranylcypromine—Alopecia—Methotrexate—lymphatic system cancer	0.000489	0.00169	CcSEcCtD
Tranylcypromine—Nausea—Vincristine—lymphatic system cancer	0.000481	0.00167	CcSEcCtD
Tranylcypromine—Nausea—Mitoxantrone—lymphatic system cancer	0.000469	0.00162	CcSEcCtD
Tranylcypromine—Vision blurred—Methotrexate—lymphatic system cancer	0.000454	0.00157	CcSEcCtD
Tranylcypromine—Anaemia—Methotrexate—lymphatic system cancer	0.000445	0.00154	CcSEcCtD
Tranylcypromine—Leukopenia—Methotrexate—lymphatic system cancer	0.000431	0.00149	CcSEcCtD
Tranylcypromine—Confusional state—Methotrexate—lymphatic system cancer	0.000397	0.00137	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000385	0.00133	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00038	0.00132	CcSEcCtD
Tranylcypromine—Anorexia—Methotrexate—lymphatic system cancer	0.000375	0.0013	CcSEcCtD
Tranylcypromine—Hypotension—Methotrexate—lymphatic system cancer	0.000367	0.00127	CcSEcCtD
Tranylcypromine—Insomnia—Methotrexate—lymphatic system cancer	0.000356	0.00123	CcSEcCtD
Tranylcypromine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000353	0.00122	CcSEcCtD
Tranylcypromine—Somnolence—Methotrexate—lymphatic system cancer	0.00035	0.00121	CcSEcCtD
Tranylcypromine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000342	0.00118	CcSEcCtD
Tranylcypromine—Pain—Methotrexate—lymphatic system cancer	0.000336	0.00116	CcSEcCtD
Tranylcypromine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000324	0.00112	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000322	0.00111	CcSEcCtD
Tranylcypromine—Urticaria—Methotrexate—lymphatic system cancer	0.000312	0.00108	CcSEcCtD
Tranylcypromine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000311	0.00108	CcSEcCtD
Tranylcypromine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000311	0.00108	CcSEcCtD
Tranylcypromine—Asthenia—Methotrexate—lymphatic system cancer	0.000282	0.000977	CcSEcCtD
Tranylcypromine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000269	0.000931	CcSEcCtD
Tranylcypromine—Dizziness—Methotrexate—lymphatic system cancer	0.00026	0.0009	CcSEcCtD
Tranylcypromine—Vomiting—Methotrexate—lymphatic system cancer	0.00025	0.000866	CcSEcCtD
Tranylcypromine—Rash—Methotrexate—lymphatic system cancer	0.000248	0.000858	CcSEcCtD
Tranylcypromine—Dermatitis—Methotrexate—lymphatic system cancer	0.000248	0.000858	CcSEcCtD
Tranylcypromine—Headache—Methotrexate—lymphatic system cancer	0.000246	0.000853	CcSEcCtD
Tranylcypromine—Nausea—Methotrexate—lymphatic system cancer	0.000234	0.000809	CcSEcCtD
